Liventa Bioscience and Medline Form Advanced Wound Care Partnership
Placental-based wound coverings to reach VA and other health care providers treating chronic wounds
(February 12, 2014) - Liventa Bioscience (formerly AFCell Medical), the trusted innovator in living donor birth tissues to advance wound care healing, has joined forces with industry leader Medline Industries, Inc. to enter the U.S. wound care market. Read the complete press release.
AFcell Medical Changes Its Name to Liventa Bioscience
West Conshohocken, Pa. – (February 6, 2014) - AFcell Medical has announced that it will now operate under the name Liventa Bioscience, effective immediately. The new name is a derivation of the words “live” and “placenta” and better reflects the company’s mission to improve the lives of patients through its placental-based advanced biologic tissue forms. Read the complete
Responds to Lawsuit
West Conshohocken, Pa. –
(April 23, 2014) - Liventa Bioscience, (formerly AFCell Medical), one of the leading innovators of allograft implants from human amniotic membrane in the United States, has received notice that MiMedx Group, Inc. (MDXG), filed a patent infringement lawsuit against it, its partner in the wound care market, Medline and Liventa’s processing partner, Musculoskeletal Transplant Foundation, Inc. (MTF). Read the complete press release.
100 Four Falls Corporate Center, Suite 660
1001 Conshohocken State Road
West Conshohocken, PA 19428
©2014 Liventa Bioscience Contact Us: dbuche@LiventaBio.com